Preparation with Recombinant Human Thyroid-Stimulating Hormone for Thyroid Remnant Ablation with 131I Is Associated with Lowered Radiotoxicity

Papillary Thyroid Carcinoma Managed at the Mayo Clinic during Six Decades (1940–1999): Temporal Trends in Initial Therapy and Long‐term Outcome in 2444 Consecutively Treated Patients

2002 • 715 citations

Second primary malignancies in thyroid cancer patients

2003 • 623 citations

TNM residual tumor classification revisited

2002 • 452 citations

The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.

1962 • 441 citations

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study

2006 • 440 citations

Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer

1990 • 413 citations

Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.

2006 • 325 citations

Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer

2001 • 301 citations

Ultrasonographic Differentiation Between Metastatic and Benign Lymph Nodes in Patients With Papillary Thyroid Carcinoma

2005 • 288 citations

Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.

2001 • 222 citations

Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?

2005 • 179 citations

A Comparison of 1850 (50 mCi) and 3700 MBq (100 mCi) 131-Iodine Administered Doses for Recombinant Thyrotropin-Stimulated Postoperative Thyroid Remnant Ablation in Differentiated Thyroid Cancer

2007 • 178 citations

Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.

1994 • 157 citations

Testicular dose and fertility in men following I¹³¹ therapy for thyroid cancer

2002 • 149 citations

Testicular function after radioiodine therapy for thyroid carcinoma

2000 • 119 citations

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma

2003 • 114 citations

Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study

2008 • 108 citations

Temporary Ovarian Failure in Thyroid Cancer Patients after Thyroid Remnant Ablation with Radioactive Iodine

1989 • 106 citations

Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.

2007 • 90 citations

rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.

2003 • 81 citations

Multifactorial analysis on the short-term side effects occurring within 96 hour after radioiodine-131 therapy for differentiated thyroid carcinoma

2004 • 63 citations

Testicular Function After Radioiodine Therapy in Patients with Thyroid Cancer

2006 • 62 citations

Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I.

2003 • 57 citations

Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited

2007 • 54 citations

Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants

2006 • 52 citations

Ovarian Function after Radioiodine Therapy in Patients with Thyroid Cancer

2005 • 44 citations

Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.

1999 • 43 citations

Alteration of Serum Enzymes in Primary Hypothyroidism

2002 • 42 citations

Gene therapy for thyroid cancer

2004 • 37 citations

Transient sialoadenitis: A complication of ¹³¹I‐metaiodobenzylguanidine therapy

2007 • 36 citations

Is Adjuvant Therapy Useful in Patients with Papillary Carcinoma Smaller Than 2 cm?

2007 • 33 citations

Hematologic changes observed following I-131 therapy for thyroid carcinoma.

1963 • 28 citations

Salivary amylase and pancreatic enzymes in serum after total body irradiation.

1986 • 28 citations

Serum amylase and tissue polypeptide antigen as biochemical indicators of salivary gland injury during iodine-131 therapy

1994 • 27 citations

Comparison between remnant and red-marrow absorbed dose in thyroid cancer patients submitted to 131I ablative therapy after rh-TSH stimulation versus hypothyroidism induced by L-thyroxine withdrawal

2007 • 26 citations

Radioiodine therapy induces dose-dependent in vivo oxidation injury: evidence by increased isoprostane 8-epi-PGF(2 alpha).

2002 • 24 citations

Assessing Hypothyroidism in the Preparation of Patients With Thyroid Cancer

2006 • 20 citations

Tratamento do carcinoma diferenciado da tireóide com iodo-131: intervenções para aumentar a dose absorvida de radiação

2005 • 13 citations

Proposal for biochemical dosimeter for prolonged space flights.

2001 • 12 citations

Sialoadenite após terapia ablativa com altas doses de radioiodo no tratamento do carcinoma diferenciado de tireóide

2004 • 12 citations

Differentiated thyroid cancer: comparison of therapeutic iodine 131 biological elimination after discontinuation of levothyroxine versus administration of recombinant human thyrotropin

2006 • 12 citations

TSH recombinante no tratamento e seguimento de pacientes com carcinoma diferenciado de tireóide: uso na prática clínica

2005 • 10 citations

Elevated urinary 8-isoprostaglandin F2α in females with Graves’ hyperthyroidism

2004 • 9 citations

Cited By (0)

No citing papers found in database